Skip to main content
Livermore
Livermore
ZHEN

Freemont Capital Pte Ltd

SEC CIK
0001796107
Latest filing
Aug 13, 2026

The latest 13F from Freemont Capital Pte Ltd covers Q2 2026 (filed Aug 13, 2026): 4 long positions worth $4.90B. The top 10 holdings make up 100.0% of the portfolio, and the largest is Linde PLC (LIN) at 53.8%. Livermore has 18 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
2
Est. −$526.1M
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. LINLinde PLC
    53.8%$2.64BHistory
  2. IFFInternational Flavors & Fragrances Inc
    41.0%$2.01BHistory
  3. SXTSensient Technologies Corp
    5.2%$252.7MHistory
  4. PDDPDD Holdings Inc.
    <0.1%$1.14MHistory

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. SXTSensient Technologies Corp
    −$524.6MReducedHistory
  2. PDDPDD Holdings Inc.
    −$1.53MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. SXTSensient Technologies Corp
    −5.95 pp11.1% → 5.2%History
  2. PDDPDD Holdings Inc.
    −0.05 pp0.1% → <0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$4.90B
−$7.76M (−0.2%) vs. prior quarter
Positions
4
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q2 2026, one quarter
Average holding period
7.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

17 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $4.91B (Q1 2026)

Q1 2021: $12.1MQ3 2022: $10.3MQ4 2022: $10.9MQ1 2023: $17.6MQ2 2023: $18.2MQ3 2023: $20.0MQ4 2023: $19.9MQ1 2024: $33.8MQ2 2024: $42.8MQ3 2024: $21.5MQ4 2024: $4.73BQ1 2025: $4.81BQ2 2025: $4.88BQ3 2025: $4.58BQ4 2025: $4.47BQ1 2026: $4.91BQ2 2026: $4.90B
Q1 2021Q2 2026
13F filings of Freemont Capital Pte Ltd by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 20264$4.90BLINIFFSXTvs. Q1 2026SEC
Q1 2026May 8, 20264$4.91BLINIFFSXTvs. Q4 2025SEC
Q4 2025Feb 9, 20265$4.47BLINIFFSXTvs. Q3 2025SEC
Q3 2025Nov 6, 202511$4.58BLINIFFSXTvs. Q2 2025SEC
Q2 2025Aug 8, 202512$4.88BLINIFFSXTvs. Q1 2025SEC
Q1 2025May 7, 20257$4.81BLINIFFSXTvs. Q4 2024SEC
Q4 2024Feb 14, 20256$4.73BIFFLINSXTvs. Q3 2024SEC
Q3 2024Nov 6, 20245$21.5MIBNHDBPDDvs. Q2 2024SEC
Q2 2024Aug 12, 20246$42.8MiShares MSCI India ETFIBNHDBvs. Q1 2024SEC
Q1 2024May 8, 20246$33.8MiShares MSCI India ETFIBNHDBvs. Q4 2023SEC
Q4 2023Feb 12, 20244$19.9MIBNHDBINFYvs. Q3 2023SEC
Q3 2023Nov 13, 20234$20.0MIBNHDBINFYvs. Q2 2023SEC
Q2 2023Aug 8, 20234$18.2MIBNHDBINFYvs. Q1 2023SEC
Q1 2023May 10, 20234$17.6MIBNHDBINFYvs. Q4 2022SEC
Q4 2022Mar 24, 2023Amended4$10.9MIBNHDBINFYvs. Q3 2022SEC
Q3 2022Nov 7, 20224$10.3MIBNINFYHDB–SEC
Q1 2021May 14, 202110$12.1MIBNDQSE–SEC

13D and 13G filings

Companies where Freemont Capital Pte Ltd reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Freemont Capital Pte Ltd does not currently report owning 5% or more of any company.

Latest filings

4 filings on file made by Freemont Capital Pte Ltd or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Freemont Capital Pte Ltd
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
SXTSensient Technologies CorpAug 13, 20264:39 PM ETWinder Pte. Ltd.and 4 others13G/A0.00%0 shares−9.80 ppfrom 9.80%Below 5%Jun 30, 2026SEC
SXTSensient Technologies CorpMay 1, 20267:18 AM ETWinder Pte. Ltd.and 4 others13G/A9.80%4.18M shares−5.10 ppfrom 14.90%Apr 30, 2026SEC
SXTSensient Technologies CorpFeb 14, 20254:49 PM ETWinder Pte. Ltd.and 4 others13G/A14.90%6.30M shares–Dec 31, 2024SEC
IFFInternational Flavors & Fragrances IncFeb 14, 20254:47 PM ETWinder Pte. Ltd.and 4 others13G/A9.90%25.4M shares–Dec 31, 2024SEC